# Lebanon Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Lebanon HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Lebanon (LBN)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $5.9M
- Products: 19
- Buyer markets: 26
- Average CAGR: +16.9%
- Global sector size: $449.9B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $265.4B | $150.3K | $96.1B | +2.4% | 17 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $26.8B | $3.1M | $17.9B | +28.3% | 11 | +0.1% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $44.2B | $628.3K | $15.7B | +18.8% | 5 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $7.9B | $24.7K | $10.7B | +1.6% | 3 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $10.2B | $3.2K | $10.5B | -24.9% | 3 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $17.5B | $492.8K | $9.7B | +73.7% | 5 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $20.4B | $304.6K | $8.8B | -0.8% | 5 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $18.1B | $2.4K | $8.1B | -9.7% | 5 | +0.0% |
| HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $6.7B | $1.2K | $6.0B | +136.4% | 2 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $10.9B | $9.4K | $5.6B | +13.3% | 3 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $8.5B | $860.8K | $5.0B | -1.6% | 3 | +0.0% |
| HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $4.8B | $31.9 | $2.8B | -55.1% | 1 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $307.5K | $1.9B | +218.8% | 1 | +0.0% |
| HS 300670 - Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $1.2B | $16.4 | $1.4B | -10.0% | 1 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $207.7 | $1.4B | +9.8% | 1 | +0.0% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $238.6 | $1.1B | -6.1% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $2.0B | $281.9 | $981.1M | -14.5% | 1 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $11.0K | $803.3M | +0.7% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $956.7M | $1.0K | $800.0M | +39.5% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $39.4B calculated opportunity across 7 products.
- Switzerland, Liechtenstein (CHE): $30.7B calculated opportunity across 2 products.
- Netherlands (NLD): $20.6B calculated opportunity across 6 products.
- Belgium (BEL): $18.1B calculated opportunity across 5 products.
- Germany (DEU): $18.0B calculated opportunity across 7 products.
- China (CHN): $11.6B calculated opportunity across 4 products.
- United Kingdom (GBR): $11.6B calculated opportunity across 6 products.
- Spain (ESP): $9.9B calculated opportunity across 5 products.
- Canada (CAN): $9.8B calculated opportunity across 6 products.
- France (FRA): $7.4B calculated opportunity across 5 products.
- Italy (ITA): $4.9B calculated opportunity across 1 products.
- Mexico (MEX): $3.6B calculated opportunity across 1 products.

## Growth stars

- HS 382319: +218.8% average CAGR, $1.9B calculated opportunity.
- HS 300214: +136.4% average CAGR, $6.0B calculated opportunity.
- HS 300439: +73.7% average CAGR, $9.7B calculated opportunity.
- HS 300290: +39.5% average CAGR, $800.0M calculated opportunity.
- HS 382499: +28.3% average CAGR, $17.9B calculated opportunity.
- HS 300215: +18.8% average CAGR, $15.7B calculated opportunity.
- HS 300212: +13.3% average CAGR, $5.6B calculated opportunity.
- HS 340220: +9.8% average CAGR, $1.4B calculated opportunity.
- HS 300490: +2.4% average CAGR, $96.1B calculated opportunity.
- HS 330210: +1.6% average CAGR, $10.7B calculated opportunity.

## Diversification opportunities

- HS 300490: 17 buyer markets, $96.1B calculated opportunity.
- HS 382499: 11 buyer markets, $17.9B calculated opportunity.
- HS 300215: 5 buyer markets, $15.7B calculated opportunity.
- HS 300439: 5 buyer markets, $9.7B calculated opportunity.
- HS 330499: 5 buyer markets, $8.8B calculated opportunity.
- HS 382200: 5 buyer markets, $8.1B calculated opportunity.
- HS 330210: 3 buyer markets, $10.7B calculated opportunity.
- HS 300220: 3 buyer markets, $10.5B calculated opportunity.
- HS 300212: 3 buyer markets, $5.6B calculated opportunity.
- HS 330300: 3 buyer markets, $5.0B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.